-transparent.png){kind=logo}
Kinetics and quantification of the sites of destruction of 111-Indium-oxine-labeled autologous platelets were investigated in eight patients with idiopathic thrombocytopenic purpura. The mean platelet count was 17 +/- 9 X 10(9)/liter; platelets were separated by differential centrifugation and labeled with 5.6 +/- 2.5 MBq 111In. Whole body and organ 111In-platelet distribution was quantitated with a scintillation camera and a computer-assisted imaging system acquisition matrix. Areas of interest were selected with the computer and organ 111In-radioactivity expressed as a percentage of whole body activity. Mean platelet survival was 49.5 +/- 29.6 hr and the survival curves were exponential. Equilibrium percentage organ 111In-radioactivity was (normal values in parentheses): spleen 33.7 +/- 8.8 (31.1 +/- 10.2); liver 16.1 +/- 9.5 (13.1 +/- 1.3); thorax 22.8 +/- 3.7 (28.2 +/- 5.6). Percentage organ 111In-activity at the time when labeled platelets had disappeared from the circulation was: spleen 44.5 +/- 16.4 (40 +/- 16); liver 16.0 +/- 11.5 (32.4 +/- 7.2); thorax 19.7 +/- 6.0 (17.7 +/- 10.3). Thorax activity corresponds to bone marrow radioactivity. Three patterns of platelet sequestration were evident. Three patients had mainly splenic sequestration, two mainly hepatic sequestration, and three diffuse reticuloendothelial system sequestration with a major component of platelets destroyed in the bone marrow. Splenectomy was performed in two patients. The pattern of 111In-platelet sequestration was not predictive of response of glucocorticoid therapy or indicative of the necessity for splenectomy. Quantitative 111In-labeled autologous platelet kinetic studies provide a new tool for the investigation of platelet disorders.U
A D Heyns, and
M G Lötter, and
P N Badenhorst, and
F de Kock, and
H Pieters, and
C Herbst, and
O R van Reenen, and
H Kotze, and
P C Minnaar
October 1978,
Mayo Clinic proceedings,
A D Heyns, and
M G Lötter, and
P N Badenhorst, and
F de Kock, and
H Pieters, and
C Herbst, and
O R van Reenen, and
H Kotze, and
P C Minnaar
January 1969,
British journal of haematology,
A D Heyns, and
M G Lötter, and
P N Badenhorst, and
F de Kock, and
H Pieters, and
C Herbst, and
O R van Reenen, and
H Kotze, and
P C Minnaar
May 1989,
Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
A D Heyns, and
M G Lötter, and
P N Badenhorst, and
F de Kock, and
H Pieters, and
C Herbst, and
O R van Reenen, and
H Kotze, and
P C Minnaar
January 1983,
Blood,
A D Heyns, and
M G Lötter, and
P N Badenhorst, and
F de Kock, and
H Pieters, and
C Herbst, and
O R van Reenen, and
H Kotze, and
P C Minnaar
September 1989,
Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
A D Heyns, and
M G Lötter, and
P N Badenhorst, and
F de Kock, and
H Pieters, and
C Herbst, and
O R van Reenen, and
H Kotze, and
P C Minnaar
January 1970,
Acta medica Academiae Scientiarum Hungaricae,
A D Heyns, and
M G Lötter, and
P N Badenhorst, and
F de Kock, and
H Pieters, and
C Herbst, and
O R van Reenen, and
H Kotze, and
P C Minnaar
March 1990,
Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
A D Heyns, and
M G Lötter, and
P N Badenhorst, and
F de Kock, and
H Pieters, and
C Herbst, and
O R van Reenen, and
H Kotze, and
P C Minnaar
November 2002,
Wiener klinische Wochenschrift,
A D Heyns, and
M G Lötter, and
P N Badenhorst, and
F de Kock, and
H Pieters, and
C Herbst, and
O R van Reenen, and
H Kotze, and
P C Minnaar
April 1982,
Seminars in thrombosis and hemostasis,
A D Heyns, and
M G Lötter, and
P N Badenhorst, and
F de Kock, and
H Pieters, and
C Herbst, and
O R van Reenen, and
H Kotze, and
P C Minnaar
September 1982,
The New England journal of medicine,
